Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.
about
Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elementsAn alternative splicing variant of the selenoprotein thioredoxin reductase is a modulator of estrogen signalingRegulation of nuclear receptor transcriptional activity by a novel DEAD box RNA helicase (DP97)Proteomic identification of Profilin1 as a corepressor of estrogen receptor alpha in MCF7 breast cancer cellsThe orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptorsSelective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifeneThe antiestrogen ICI 182,780 decreases the expression of estrogen receptor-alpha but has no effect on estrogen receptor-beta and androgen receptor in rat efferent ductulesERbeta Binds N-CoR in the Presence of Estrogens via an LXXLL-like Motif in the N-CoR C-terminusRecognition and accommodation at the androgen receptor coactivator binding interfaceEstrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer.Estrogen receptor transcription and transactivation: Basic aspects of estrogen action.Problems for risk assessment of endocrine-active estrogenic compoundsLarge effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activityProbing protein conformational changes in living cells by using designer binding proteins: application to the estrogen receptor.Structural insights into corepressor recognition by antagonist-bound estrogen receptorsSKF-82958 is a subtype-selective estrogen receptor-alpha (ERalpha ) agonist that induces functional interactions between ERalpha and AP-1Recruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands. Influence of DNA-heterodimer interactionsExtracellular signal-regulated kinase 7, a regulator of hormone-dependent estrogen receptor destruction.Truncated estrogen receptor product-1 suppresses estrogen receptor transactivation by dimerization with estrogen receptors alpha and beta.Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics.The ligand-mediated nuclear mobility and interaction with estrogen-responsive elements of estrogen receptors are subtype specific.Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta.Sex hormones: a role in the control of multiple sclerosis?Short peptides as biosensor transducers.A novel pesticide-induced conformational state of the oestrogen receptor ligand-binding domain, detected by conformation-specific peptide binding.The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs.Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors.Hormone replacement therapy and fractures in older adults.Convergent evolution with combinatorial peptides.Minimal activators that bind to the KIX domain of p300/CBP identified by phage display screening.Differential biochemical and cellular actions of Premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combinationEstrogen receptor and the SERM concept.Minireview: Not picking pockets: nuclear receptor alternate-site modulators (NRAMs)Molecular and cellular mechanisms of estrogen action on the skeleton.The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytesDelineation of a unique protein-protein interaction site on the surface of the estrogen receptor.Regulation of cholangiocyte proliferation.Noncanonical mechanisms to regulate nuclear receptor signaling.The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer.Selective estrogen receptor modulators: tissue selectivity and differential uterine effects.
P2860
Q22253217-48E660E8-98B2-4931-9258-C20D40068E63Q24297014-05541977-A5ED-43C3-82DC-39BA9C2207A6Q24323211-DFC6DF0A-F3FC-49B7-9F4E-EC92F22DF05AQ24338281-37392C2D-16E2-433A-A591-815B834C7870Q24554322-83A5DE99-EB09-4692-BB84-8AF8C7FE3333Q24652524-794EAF6B-7115-41B2-84AE-850D62EA6119Q24791579-049071AF-DDD6-4E7A-8D4C-DA0DFEB18389Q24793018-10E34CDE-5B53-4246-8D15-B7E55A25D99DQ24799399-4ED1DE90-232D-4825-A91B-22AE0AED2846Q24800731-A2992036-4B06-41BD-9F1B-A35D103F6EF1Q24800814-0F6947F0-0564-43A7-935E-AF89BF4FC9ACQ24812789-7CF1AC3C-57EA-407B-B47F-571111888351Q24815103-84AAAAC1-5C1E-4CE5-9201-A27B0AF4CD8AQ27637534-F173EF69-E5EF-4FD9-AC04-CCC9C9FD736EQ27643750-9C8B2B89-8C83-4B9D-AE2F-BC23C8EFF413Q28204373-055FD545-3C22-43B1-9651-237EA304D4C4Q28377418-27CF1D7F-9668-4A04-BCCD-7958A684C5A7Q28580406-09F47C1A-07EC-4B0A-9E67-35EC907C258FQ30305439-25517968-0AC0-4880-BBD5-99F701DDBD17Q30418832-5F6ECB1E-0247-437A-BD83-6F80C16B4F77Q30540362-781F0A06-F411-40CB-982E-1F064BD12A54Q30815190-E4A279E7-88A0-4CFF-BB0E-F5BDC83A2942Q31037759-852871D4-9A6F-4D2B-BD19-ADF43334E76FQ31043462-3FECBF6C-BCC2-4C53-8B26-E339DE48BF0AQ31140418-292EED66-897D-4D6B-815A-3068D0057A9DQ31140532-4D1DB4F6-B637-434D-BBC1-A04A935CAB5CQ31568030-AF28AEC6-2D63-46AB-96AB-CCDAA5077660Q32028226-2FFB9CFE-660E-4915-A15A-CFC8842C29A5Q33180988-181044E7-F3F1-4685-8BE6-F52D847F0249Q33181175-AD9A0AE4-015C-477B-A05B-3B878F432227Q33642558-BC8D68E7-9D9C-4D87-815F-9511CD8D2501Q33757725-E6694D31-1AEA-45C3-8FA5-006DB3F2A726Q33780204-D8AA422F-1A16-4EE0-8C41-403114EB15E2Q33813423-91CCC0E0-692A-4E13-8520-743B639855C6Q33815579-BC288D07-3E96-4C58-92D8-DA2CAE70D24FQ33928526-29A9E3B0-ED78-4344-88BA-02B02CD743ADQ34229378-5164AE23-E076-4472-8A64-5C3934E5FB15Q34338685-60490F13-4374-4358-BF90-621FD14865B2Q34534031-EF05458F-96EA-4BE9-80BF-AD9868E7B438Q34575198-FBEF0883-8330-4B08-98E7-642024542022
P2860
Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Estrogen receptor (ER) modulat ...... anges in ER alpha and ER beta.
@ast
Estrogen receptor (ER) modulat ...... anges in ER alpha and ER beta.
@en
type
label
Estrogen receptor (ER) modulat ...... anges in ER alpha and ER beta.
@ast
Estrogen receptor (ER) modulat ...... anges in ER alpha and ER beta.
@en
prefLabel
Estrogen receptor (ER) modulat ...... anges in ER alpha and ER beta.
@ast
Estrogen receptor (ER) modulat ...... anges in ER alpha and ER beta.
@en
P2093
P2860
P356
P1476
Estrogen receptor (ER) modulat ...... hanges in ER alpha and ER beta
@en
P2093
D J Christensen
D M Fowlkes
D P McDonnell
E B Gottlin
J D Norris
K M Padilla
L M Ballas
P2860
P304
P356
10.1073/PNAS.96.7.3999
P407
P577
1999-03-01T00:00:00Z